Tuberculosis News and Research

Latest Tuberculosis News and Research

Report by aid watchdog group finds many international donors lack transparency

IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."

18 Nov 2011

South African public health experts urge countries to use TRIPS to produce generic drugs, IPS reports

South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.

18 Nov 2011

Eli Lilly provides $4M in additional funding to IDRI for new TB therapies

Eli Lilly and Company today announced that it is providing more than $4 million in additional funding to the Infectious Disease Research Institute. The funding will allow IDRI to continue its early phase drug discovery efforts focused on identifying new and better therapies in the fight against tuberculosis, including multidrug-resistant strains known as MDR-TB.

17 Nov 2011

New collaboration enables information sharing to aid in development of TB drug candidates

In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."

17 Nov 2011

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

In a review study, researchers from Tufts University School of Medicine zero in on the controversial, non-therapeutic use of antibiotics in food animals and fish farming as a cause of antibiotic resistance.

16 Nov 2011

Streamlining clinical trials review process to speed up delivery of drugs to those in need

In this Atlantic opinion piece, Amanda Glassman, director of Global Health Policy at the Center for Global Development (CGD), reports on how lengthy, inefficient review processes for drug and vaccine candidates waiting in the pipeline for late stages of clinical development is keeping promising new medicines, vaccines, and diagnostic techniques from reaching millions in need.

16 Nov 2011

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.

16 Nov 2011

Clinton's speech prioritizing creation of 'Aids-free generation' may shape future of U.S. global health strategy, analysts say

U.S. Secretary of State Hillary Clinton's November 8 speech at the NIH, in which she called for the creation of an "AIDS-free generation" through the use of combination prevention strategies, "could be more than just political lip-service: it may also shape the next several years of U.S. global health programming and funding, analysts say," PlusNews reports.

15 Nov 2011

VOA News examines Foundation's efforts to treat MDR-TB patients in North Korea

VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.

15 Nov 2011

Mtb produces specific protein that allows it to defuse and bypass body's security system

Tuberculosis, which kills over 2 million people each year, is caused primarily by infectious bacteria known as Mycobacterium tuberculosis - or Mtb. Mtb targets human immune cells as part of its strategy to avoid detection, effectively neutralizing the body's immune response.

15 Nov 2011

Researchers in Philippines develop machine to quickly detect drug-resistant TB

In this post in the Global Post's "Global Pulse" blog, journalist John Donnelly reports on how a machine developed by researchers at the TB Laboratory at the Lung Center of the Philippines "that can detect multi-drug resistant tuberculosis (MDR-TB) in record time may revolutionize TB treatment."

15 Nov 2011

Cambodia set to distribute more than 2.5M mosquito nets by end of year

"Millions of Cambodians are set to receive insecticide-treated mosquito nets as part of a government-led effort to mitigate the risk of malaria and dengue fever," IRIN reports.

14 Nov 2011

Annual European CDC report says infectious diseases, drug resistance are concerns

"Europe's health is suffering, with around 80,000 cases of tuberculosis infection a year and serious problems with measles, HIV and threats from 'superbug' infections, an annual health report" from the European Centre for Disease Prevention and Control (ECDC) said Thursday, Reuters reports.

11 Nov 2011

Translating science into service delivery to achieve Clinton's vision of an AIDS-free generation

In this post in the Huffington Post's "Impact" blog, U.S. Global AIDS Coordinator Ambassador Eric Goosby responds to Secretary of State Hillary Rodham Clinton's speech on HIV/AIDS given at the NIH on Wednesday, in which she called for an "AIDS-free generation," writing that "her vision was an affirmation of the progress made over the past decade, and a mandate to redouble our efforts with global partners to bring the latest scientific advances to bear in order to save lives."

11 Nov 2011

PlusNews examines difficulties in diagnosing, treating MDR-TB in children

PlusNews examines the difficulties in diagnosing and treating multidrug resistant tuberculosis (MDR-TB) in children, writing, "With weaker immune systems, children who contract TB -- most often from parents -- progress to active disease in about a year. But just how many children are affected is not known as there is almost no research into children and MDR-TB -- and very little useful guidance on how to treat them."

10 Nov 2011

Global Fund committed to transparency in shift from emergency response to sustainable funding mechanism

Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes about a report issued in September by an independent high-level panel commissioned by the Global Fund in a post in the Huffington Post's "Impact" blog, saying the report "focuses on the Global Fund's transition from a highly effective emergency response to the three pandemics, to a long-term sustainable mechanism for ensuring that its lifesaving work can continue in times of limited resources."

9 Nov 2011

Indian researchers receive grant to develop 'E-Nose' for quick TB diagnosis

"Researchers are developing an electronic nose that would sniff out tuberculosis (TB) like a Breathalyzer detects alcohol, putting an end to current time-consuming tests and possibly saving hundreds of thousands of lives each year," the Globe and Mail reports (D'Aliesio, 11/7).

9 Nov 2011

Five-year results from Abbott's HUMIRA ATLAS study on ankylosing spondylitis

Abbott today announced five-year results from the open-label extension of the ATLAS study, which evaluated the long-term impact of treatment with HUMIRA (adalimumab) on disease activity, including spinal mobility in patients with active ankylosing spondylitis.

8 Nov 2011

Electronic Nose can diagnose TB in symptomatic patients

A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.

7 Nov 2011

Abbott announces results from HUMIRA Phase 3 study on axSpA

Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.

7 Nov 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

Report by aid watchdog group finds many international donors lack transparency

South African public health experts urge countries to use TRIPS to produce generic drugs, IPS reports

Eli Lilly provides $4M in additional funding to IDRI for new TB therapies

New collaboration enables information sharing to aid in development of TB drug candidates

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

Streamlining clinical trials review process to speed up delivery of drugs to those in need

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

Clinton's speech prioritizing creation of 'Aids-free generation' may shape future of U.S. global health strategy, analysts say

VOA News examines Foundation's efforts to treat MDR-TB patients in North Korea

Mtb produces specific protein that allows it to defuse and bypass body's security system

Researchers in Philippines develop machine to quickly detect drug-resistant TB

Cambodia set to distribute more than 2.5M mosquito nets by end of year

Annual European CDC report says infectious diseases, drug resistance are concerns

Translating science into service delivery to achieve Clinton's vision of an AIDS-free generation

PlusNews examines difficulties in diagnosing, treating MDR-TB in children

Global Fund committed to transparency in shift from emergency response to sustainable funding mechanism

Indian researchers receive grant to develop 'E-Nose' for quick TB diagnosis

Five-year results from Abbott's HUMIRA ATLAS study on ankylosing spondylitis

Electronic Nose can diagnose TB in symptomatic patients

Abbott announces results from HUMIRA Phase 3 study on axSpA

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Tuberculosis News and Research

Latest Tuberculosis News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in